Continuous Glucose Monitoring in Inpatients

NCT06329297 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2026-04-23

No results posted yet for this study

Summary

The purpose of this study is to contribute to current research regarding the feasibility and accuracy of CGM in the hospital setting for both the medical and cardiovascular intensive care (ICU) patient populations.

Conditions

Interventions

DEVICE

CGM monitor

blood glucose sensor used to monitor interstitial glucose

Sponsors & Collaborators

  • Parkview Health

    lead OTHER

Principal Investigators

  • Jan R Powers · Parkview Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-31
Primary Completion
2025-10-31
Completion
2025-12-31
FDA Device
Yes

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06329297 on ClinicalTrials.gov